View
 

Metabolic Syndrome

Page history last edited by Kirsten Holme 2 years, 1 month ago

This programme is developed by the Hungarian National Pharmaceutical Care Committee and supported by EuroPharm Forum. The Metabolic Syndrome working group will use this national programme as a template for a more general European programme, see working plan below.

 

Pharmacy-based Metabolic Syndrome Management Programme in Hungary

 

Poster presented at FIP concerning Pharmacy-based Metabolic Syndrome Management Programme in Hungary

 

 

 

Metabolic Syndrome Pharmaceutical Care project working plan

 

Background

The EuroPharm Forum has developed many disease specific pharmaceutical care programs (like diabetes, hypertension) which are related to the cardiovascular disease field. In the 21st century, when 50% of all mortality causes are due to cardiovascular diseases (source: The European Health Report 2009), it is vital to have an integrated approach. The Metabolic Syndrome Protocol reflects to this need, because it incorporates the obesity, diabetes, hypertension and dyslipidaemia field, in a three prevention (health promotion, screening, follow up of diagnosed patient) level approach. The protocol was developed by the Hungarian National Committee of Pharmaceutical Care in joint collaboration with EuroPharm Forum.

 

The aim of the project

  1. To develop the European version of the Metabolic Syndrome protocol, which gives an easy to use tool for every country to implement the protocol in their own country
  2. To collect all the relevant information on European level, which can help the pharmacy profession
    1. to underlay the importance of pharmacists involvement in the cardiovascular disease management
    2. to prove the effectiveness of pharmacist interventions in this field

 

The time-frame and structure of the project

To provide sufficient data regarding the burden of cardiovascular diseases

  • Place
    • EuroPharm Forum observatory, with relevant links, and documents
  • Method
    • Literature review

To map the ongoing similar cardiovascular pharmaceutical care diseases services

  • Place
    • EuroPharm Forum observatory, with relevant links, and documents
  • Method
    • Newsflash info (if your country has some similar program please provide a short description on the Observatory)
    • Review of the existing country database
    • Presentation on working seminar in Budapest

To rewrite the Metabolic Syndrome Pharmaceutical Care program with the European data, and European approach, and incorporate all the proposed changes based on the other country experiences.

  • Method
    • In the protocol substitute the Hungarian specificity with European data
    • Incorporate the proposals, and the best practice examples of other countries

 

Please comment and contribute to the developement of materials for Metabolic Syndrome

Submit your comments below or to the secretariat@europharmforum.org

 

Comments (1)

Julius C. Alegarbes,RPh.,PharmD. said

at 8:56 am on May 7, 2010

This is a very good project increase the potentials of pharmaceutical care...especially in chronic diseases like syndrome x and CVD...I hopefully we can share our thoughts and knowledge regarding this..thank you

You don't have permission to comment on this page.